Persister cell plasticity in tumour drug resistance
Seminars in Cell & Developmental Biology · 2024
DOI: 10.1016/j.semcdb.2023.11.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cell & Developmental Biology, 2024. Verfasst von Paul C McDonald und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Cancer Research Society, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The emergence of therapeutic resistance remains a formidable barrier to durable responses by cancer patients and is a major cause of cancer-related deaths. It is increasingly recognized that non-genetic mechanisms of acquired resistance are important in many cancers. These mechanisms of resistance rely on inherent cellular plasticity where cancer cells can switch between multiple phenotypic states without genetic alterations, providing a dynamic, reversible resistance landscape. Such mechanisms underlie the generation of drug-tolerant persister (DTP) cells, a subpopulation of tumour cells that contributes to heterogeneity within tumours and that supports therapeutic resistance. In this review, we provide an overview of the major features of DTP cells, focusing on phenotypic and metabolic plasticity as two key drivers of tolerance and persistence. We discuss the link between DTP cell plasticity and the potential vulnerability of these cells to ferroptosis. We also discuss the relationship between DTP cells and cells that survive the induction of apoptosis, a process termed anastasis, and discuss the properties of such cells in the context of increased metastatic potential and sensitivity to cell death mechanisms such as ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
- Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electroni…
Förderung
- Cancer Research Society
- Canadian Institutes of Health Research
Zitieren
APA
McDonald, P. C., & Dedhar, S. (2024). Persister cell plasticity in tumour drug resistance. Seminars in Cell & Developmental Biology. https://doi.org/10.1016/j.semcdb.2023.11.003
Vancouver
McDonald PC, Dedhar S. Persister cell plasticity in tumour drug resistance. Seminars in Cell & Developmental Biology. 2024. doi:10.1016/j.semcdb.2023.11.003
BibTeX
@article{McDonald2024,
author = {McDonald, Paul C and Dedhar, Shoukat},
title = {Persister cell plasticity in tumour drug resistance},
journal = {Seminars in Cell & Developmental Biology},
year = {2024},
doi = {10.1016/j.semcdb.2023.11.003}
}
EUVIMED